|
1. Brocklehurst. J.C. Urology in the elderly.1984 2. Cook, N. S. The Pharmacology of Potassium Channels and Their Therapeutic Potential. Trends Pharmacol. Sci. 1988, 9, 21-28. 3. Yoshizumi. K,; Ikeda. S.; Goto. K.; Morita. T,; Nisimura. N.; Sukamoto. T. and Yoshino. K. Synthesis and Structure-Activity Relation of Novel Phenylcyanoguanidine Derivatives as Potassium Channel Openers. Chem. Pharm. Bull.1996, 44, 2042-2050. 4. Taira, N. Similarity and Dissimilarity and Mechanism of Action between Nicorandil and Classical Nitrates: An overview. J.Cardiovasc Pharmacol.1978,10, S1-9 5. Steinberg, M. I.; Robertson, D. W. The Body*s Potassium Channels. CHEMTECH 1990, 432-438. 6. Noma, A. ATP-regulated K+ Channels in Cardiac Muscle. Nature 1983, 305, 147-148. 7. Spruce, A. E. ; Standen, N. B.; Stanfield, P. R. Studies of the Unitary Properties of Adenosine-5*-Triphosphate-Regulated Potassium Channels of Frog Skeletal Muscle. J. Physiol. 1987, 382, 213-236. 8. Cook, D. L.; Hales, C. N. Intracellular ATP directly Blocks K+ Channels in Pancreatic b-cells. Nature 1984, 311, 271. 9. Wang, W.; Sackin, H.; Giebisch, G. Renal Potassium Channels and Their Regulation. Ann. Rev. Physiol. 1992, 54, 81-96. 10. Ben-Ari, Y.; Krnjevic, K.; Crepel, V. Activators of ATP-Sensitive K+ Channels Reduce Anoxic Depolarization in CA3 Hippocalpal Neurons. Neuroscience 1990, 37, 55-60. 11. Bernardi, H.; Fosset, M.; Lazdunsk, M. Characterization, Purification and Affinity Labeling of The Brain [3H] Glibenclamide-Binding Protein, A putative Neuronal ATP-Regulated K+ Channel. Proc. Natl. Acad. Sci. USA 1988, 85, 9816-9820 12. Atwal, K. S. Advances in The Structure-Activity Relationships, Mechanisms of Action, and Therapeutic Utilitres of ATP-Sensitive Potassium Channel Openners. Drug Development Res. 1994, 33, 250-262. 13. Special Issue on ATP Sensitive Potassium Channels. Cardiovasc. Res. 1984, 28, 726-930. 14. Evans, J. M.; Fake, C. S.; Hamilton, T. C.; Poyser, R. H. and Watts, E. A. Synthesis and Antihypertensive Activity of Substituted trans-4-Amino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3-ol. J. Med. Chem. 1983, 26, 1582-1589. 15. Evans, J. M.; Fake, C. S.; Hamilton, T. C.; Poyserr, R. H.; Showell, G. A. Synthesis and Antihypertensive Activity of 6,7-Disubstituted trans-4-Amino-3,4-dihydro-2, 2-dimethyl-2H-1-benzopyran-3-ol. J. Med. Chem. 1984, 27, 1127-1131. 16. Ashwood, V. A.; Buckingham, R. E.; Cassidy, F.; Evanss, J. M.; Faruk, E. A.; Hamilton, T. C.; Nash, D. J.; Stemp, G.; Willcocks, K. Synthesis and Antihypertensive Activity of 4-(Cyclicamido)-2H-1-benzopyrans. J. Med. Chem. 1986, 29, 2194-2201. 17. Hamiltonm T. C.; Weir, S. W. and Weston, A. H. Comparison of The Effects of BRL 34915 and Verapamil on Electrical And Mechanical Activity in Rat Portal Vein. Br. J. Pharmac. 1986, 88, 103-111. 18. Zografos, P.; Li, J. H.; Kau, S. T. Comparison of The in Vitro Effects of K+ Channel Modulators on Detrusor and Portal Vein Strips form Guinea Pigs. Pharmacol.1992, 45, 216-230 19. Ashwood, V. A.; Cassidy, F.; Coldwell, /m. C.; Evanss, J. M.; Hamilton, T. C.; Howlett, D. R.; Smith, D. M.; Stemp, G. Synthesis and Antihypertensive Activity of 4-(Substitutedcarbonylamido)-2H-1-benzopyrans. J. Med. Chem. 1990, 33, 2667-2672. 20. Burrell, G.; Cassidy, F.; Evans, J. M.; Lightowler, D.; Stemp, G. Variation in the Aromatic Ring of cromakalim : Antihypertensive Activity of Pyranopyridines and 6-Alkyl-2H-1-benzopyrans. J. Med. Chem. 1990, 33, 3023-3027. 21. Atwal, K. S.; Ferrara, F. N.; Ding, C. Z.; Grover, G. J,; Sleph, P. G.; Dzwonczyk, S,; Baird, A. J. and Normandin, D. E. Cardioselective Antiischemic ATP-Sensitive Potassium Channel Openers. 4. Structure-Activity Studied on Benzopyranyl-cyanoguanidines : Replacement of the Benzopyran Portion. J. Med. Chem. 1996, 39, 304-313. 22. Thomas, W. A.; Whitcombe, I. W. A. Conformational Behaviour of cromakalim and Related Potassium Channel Activators. J. Chem. Soc. Chem. Commum, 1990, 528-529. 23. Dalonzo. A. J; Darbenzio. R. B.; Swter. J. C.; Hess. T. A.; Grover. G. J.; Sleph. P.G. Normandin. D. E. and Lodge. N.J. A Comparison Between the Effect of BMS-180448, a Novel K+ Channel Opener, andCromakalim in Rat and Dog. Eur. J. Pharmacol, 1995, 294, 271-280. 24. Sato, H.; Koga, H.; Ishizana, T.; Makino, T.; Kuromaru, K.; Taka, N.; Takahashi, T.; Sato, T.; Nabata, H. Bioorg. Med. Chem. Lett. 1993, 3, 2624-2627. 25. Tamura, K.; Suzuki, Y.; Yoshida, S.; Nabata, H. Action of KC-399, a Newly Synthesized Potassium Channel Opener, on Mechanical Activity and 86Rb Efflux in Rat Aorta. J. Cardiovasc. Pharmacol. 1994, 23, 220-226. 26. Uchida, W.; Hirano, Y.; Shirai, Y.; Taguchi, T.; Masuda, N.; Shibasaki, K.; Hirano, S.; Matsumoto, Y.; Tsuzuki, R.; Yanagisawa, I.; Satoh, N.; Takenaka, T. Potassium Channel-Opening and Vasorelaxant Profiles of a Novel Compound YM099 in Rat Isolated portal Vein and Rabbit Isolated Aorta. Arch. Int. Pharmacodyn. 1994, 327, 330-343. 27. Uchida, W.; Hirano, Y.; Taguchi, T.; Masuda, N.; Shiral, Y.; Satoh, N.; Takenaka, T. Cardiovascular Effect of YM099, a Novel K+ Channel Openner, in Anesthtized and Conscious Dog. Eur. J. Pharmacol, 1994, 264, 285-293. 28. Uchida, W.; Masuda, N.; Taguch, T., Shibasaki, K.; Shirai, Y.; Asano, M.; Matsumoto, Y.; Tsuzuki, R.; Fujikira, T.; Takeraka, T. Pharmacologic Profiles of YM-934, a Novel Potassium Channel Opener. J. Cardiovasc, Pharmacol. 1994, 23, 180-187. 29. Yamada, M.; Terzic, A.; Findlay, I.; Jahangir, A.; Shen, W.K.; Kurachi, Y. Antihypertensive and Cardiovascular Effect of a New Potassium Channel Opener,TCV-295, in Rats and Dogs. J. Pharmacol. Exp. Ther. 1993, 267, 1544-1553. 30. Russell, K.; Brown, F. J.; Warwick, P.; Forst, I.; Grant, T.; Howe, B.;Kau, S. T.; Li, J. H.; McLaren, F. M.; Shapiro, H. S.; Trivedi, S. A Highly Potent Series of Fluoroalkyl Benzoxazine Pyridine Potassium Channel Openers. Bioorg. Med. Chem. Lett. 1993, 3, 2727-2728 31. Burrell, G.; Evanss, J. M.; Hardley, M. S.; Hicks, F.; Stemp, G. Benzopyran Potassium Channel Activators Related To Cromakalim-Heterocyclic Amide Replacements At Position 4. Bioorg. Med. Chem. Lett. 1994, 4, 1285-1290 32. Damiano, B. P.; Giardino, E. C.; Haertlein, B. J.; Stump, G. L.; Mitchell, J. A.; Falotico, R. Cardiovascular Profile of RWJ29009, a New Potassium Channel Activator, in Anesthetized and Conscious Dog. J. Cardiovasc. Pharmacol. 1994, 23, 300-310. 33. Katz, L. B.; Giardino, E. C.; Salata, J. J.; Moore, J. B.; Falotico, R. RWJ26629, a New Potassium Channel Opener and Vascular Smooth Muscle Relaxant : APotential Antihypertensive and Antiaginal Agent. J. Pharmacol., Exp. Ther. 1993, 267, 648-656. 34. Itoh, T.; Ito, S.; Shafiq, J.; Suzuki, H. Effect of a Newly Synthesized K+ Channel Opener, Y-26763, on Noradrenaline-Induced Ca2+ Mobilization in Smooth Muscle of the Rabbit Mesenteric Artery. Br. J. Pharmacol. 1994, 111, 165-172 35. Terzic, A.; Jahangir, A.; Kurachi, Y. HOE-234, a Second Generation K+ Channel Opener, Antagonizes the ATP-Dependent Gating of Cardiac ATP-Sensitive K+ Channels.J. Pharmacol. Exp. Ther. 1994, 268, 818-825. 36. Kamei, K.; Yoshida, S.; Imagawa, J. I.; Nabatu, H.; Kuriyawa, H. Regional and Species Difference in Glyburide-Sensitive K+ Channels in Airway Smooth Muscles as Estimated frim Actions of KC-128 and Levcromakalim. Br. J. Pharmacol. 1994, 113, 889-897. 37. Kusumoto, K.; Awane, Y.; Kitayoshi. T.; Fujiwara, S.; Hashigushi, S.; Teraahita.; Shiraishi, M.; Watanabe, T. J., Pharmacologic Profiles of YM934, a Novel Potassium Channel Opener.; J. Cardiovasc. Pharmacol. 1994, 23, 180-187. 38. Smith, D. G.; Buckle, D. R.; Faller, A. and Pinto, I. Pyrrole Analogues of the Pyrrolidinone Moiety of the Potassium Channel Activator Cromakalim as Relaxant of Guinea Pig Trachealis. L. Bioorg Med. Chem. Lett., 1992, 2, 1595-1598. 39. Yoo, S. E.; Kim, S. J.; Shin, H. S.; Hong, K.W. Benzopyran Sulfoxide Derivatives as New Potassium Channel Activator. Bioorg. Med. Chem. Lett., 1993, 3, 553-554. 40. Gadwood, R. C.; Kamdar, B. V.; Cipkus Dubray, L. A.; Wolfe, M. L.; Smith, M. P.; Watt, W.; Mizsak, S. A.; Groppi, V. E. Synthesis and Biological Activity of Spirocyclic Benzopyran Imidazolone Potassium Channel Openners. J. Med. Chem. 1993, 36., 1480-1487. 41. Gadwood R. C.; Thomasco, L. M.;Groppi, V. E.; Burrnett, B. A.; Humphrey, S. J.; Smith, M. P. and Watt, W., 207th ACS National Meeting, San Diegp, CA, March 13-18, Abstract 223, 1994. 42. Almansa, C.; Gomez, L. A.; Cavalacanti, F. L.; Rodriguez, R.; Carceller, E.; Bartroli, J.; Garcia-R., J. and Forn, J. 2,2-Dialkylnaphthalen-1-ones as New Potassium Channel Activators. J. Med. Chem., 1993, 36, 2121-2133. 43. Perez-Vizcaino, F.; Casis, O.; Rodriguez, R.; Gomez, L. A.; Garcia Rafanell, J. and Tamargo, J. Effect of Novel Potassium Channel Opener, UR-8225, on Contractile Responses in Rat Isolated Smooth Muscle. Br. J. Pharmacol. 1993, 110, 1165-1171. 44. Berthelon, J-J.; Brunet, M.; Noblet, M.; Durbin, P. Guerrier, D. and Luong, T. Patent Application, WO/9413658, 1994. 45. Empfield, J. R.; Mayhugh, D.; Ohnmacht, C. J.; Frank, C. ; Grant, T.; Li, J. 4-Sulfonamidoanilide Tertiary Carbinols: A Novel Series of Potassium Channel Openers. Bioorg. Med. Chem. Lett. 1997, 7, 775-778. 46. Howe,B. B; Halterman,T. J; Yochim, C.L; Do, M. L; Pettinger, S. J ; Stow, R. B; Ohnmacht, C. J; James, K. R; Trainor, D. A; Browin, F. J; Kau,S.T. ZENECA ZD6169 : A Novel KATP Channel Opener with in Vivo Selectivity for Urinary Bladder. J. Pharmacol. Exp.Ther.1995, 274, 884-890. 47. Cassidy, F.; Evanss, J. M.; Smith, D. M.; Stemp, G.; Edge, and Williams, D. J. Conformational Analysis of the Novel Antihypertensive Agent cromakalim (BRL 34915). J. Chem. Soc. Chem. Commun. 1989, 377-378. 48. Attwood, M. R.; Jones, P. S.; Kay, P. B.; Paciorek, P. M. and Redshaw, S. The Design of a Novel Class of Potassium Channel Activiting Drugs, 2-(2,2-Dimethylbenzopyran-4-yl)-Pyridine-1-Oxides. Life Sciences, 1991, 48, 803-810. 49. Part of this work has been published. See: Cheng, C.Y.; Chiu, H. I.; Chang, M. ; Lin, Y. C.; Tsai, M. C.; Yu, H. C. Synthesis of 2,3,4a,11b-Tetrahydro-oxazino{2,3,-c}benzopyran-9-carbonitriles as ATP-Sensitive Potassium Channel Openers. Bioorg. Med. Chem. Lett. 1998, 8, 463-468. 50. Chang, M. J. Ph. D. Thesis, Synthesie and Pharmacology of Novel Benzopyran Derivatives as Potassium Channel Activators. Jan. 1997 51. Lee, N. H.; Muci, A. R. ; Jacobsen, E. N. Enantiomerically Pure Exoxychromans via Asymmetric Catalysis. Tetrahedron Lett. 1991, 32, 5055-5058. 52. Houge-Frydrych, C. S. V.; Pinto, I. L. An UmusualHydroxyl Inversion By DAST . Tetrahedron Lett. 1989, 30, 3349-3350. 53. Fukuyama, T.; Jow, C.-K.; Cheung, M. 2- and 4-Nitrobenzenesulfonamides: Exceptionally Versatile Means for Preparation of Secondary Amines and Protection of Amines. Tetrahedron Lett. 1995, 36, 6373-6380. 54. 化合物37d-e及化合物38a-e係由邱欣怡同學所製備的. 55. Quast, U.; Villhauer, E. B. The Individual Enantiomers of Cis-Coromakalim Possess K+ Channel Opening Activity. Eur. J. Pharmacol. 1993, 245, 165-171. 56. Still, W. C.; Kahn, A. Rapid Chromatographic Technique for Preparative Separations with Moderate Resolution. J. Org. Chem.1978, 4, 73-80.
|